SPRY2 and malignant colon neoplasm: In another study by Feng et al., reduced expression of Spry2 was observed more in patients with stage III or IV colon cancer than those with stage II disease, suggesting that downregulation of Spry2 in colon cancer may be associated with tumor invasion and metastasis [10].